Department of Internal Medicine, St Elizabeth's Medical Center, 736 Cambridge St., Boston, MA 02135, USA.
Department of Medicine, Tufts University School of Medicine, Boston, MA 02111, USA.
Int J Mol Sci. 2022 Oct 19;23(20):12525. doi: 10.3390/ijms232012525.
Central nervous system (CNS) metastases are common in breast cancer (BC) patients and are particularly relevant as new treatments for BC are prolonging survival. Here, we review advances in the treatment of CNS metastases from BC, including radiotherapy, systemic therapies, and the evolving role of immunotherapy. The use of radiotherapy and chemotherapy is the cornerstone of treatment for CNS metastases. However, new targeted therapies have recently been developed, including anti-HER2 agents and antibody-drug conjugates that have presented promising results for the treatment of these patients.
中枢神经系统(CNS)转移在乳腺癌(BC)患者中很常见,由于新的 BC 治疗方法正在延长患者的生存期,因此这一点尤其重要。在这里,我们回顾了 BC 中枢神经系统转移治疗方面的进展,包括放疗、全身治疗以及免疫治疗的不断发展。放疗和化疗的应用是 CNS 转移治疗的基石。然而,最近已经开发出了新的靶向治疗方法,包括抗 HER2 药物和抗体药物偶联物,这些方法为治疗这些患者带来了有希望的结果。